(Q43011834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Savitri Krishnamurthy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Massimo Cristofanilli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Balraj Singh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

James Reuben

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hui Gao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Eleni Andreopoulou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Carolyn S Hall

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ashutosh Lodhi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Summer Jackson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anthony Lucci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

3330-3337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564098%20AND%20SRC:MED&resulttype=core&format=json

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

Systemic spread is an early step in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021

HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25145

7 January 2021